BMO Capital Reiterates Outperform Rating on Replimune Group (REPL), PT $27, 'we see a long road ahead'
Tweet Send to a Friend
BMO Capital analyst Evan Seigerman reiterated an Outperform rating and $27.00 price target on Replimune Group (NASDAQ: REPL).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
